MANSERVIGI, Roberto
 Distribuzione geografica
Continente #
NA - Nord America 10.524
AS - Asia 5.172
EU - Europa 2.889
SA - Sud America 829
AF - Africa 108
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 5
Totale 19.540
Nazione #
US - Stati Uniti d'America 10.310
SG - Singapore 1.851
CN - Cina 1.473
BR - Brasile 630
UA - Ucraina 606
VN - Vietnam 540
GB - Regno Unito 433
DE - Germania 424
HK - Hong Kong 406
IT - Italia 359
TR - Turchia 348
FR - Francia 200
PL - Polonia 184
FI - Finlandia 177
SE - Svezia 161
RU - Federazione Russa 128
BD - Bangladesh 121
JP - Giappone 106
CA - Canada 100
IN - India 91
MX - Messico 75
AR - Argentina 72
ZA - Sudafrica 52
IQ - Iraq 48
NL - Olanda 47
BE - Belgio 40
AT - Austria 36
EC - Ecuador 33
CO - Colombia 31
ES - Italia 28
ID - Indonesia 28
VE - Venezuela 24
PK - Pakistan 23
UZ - Uzbekistan 16
LT - Lituania 15
IR - Iran 14
SA - Arabia Saudita 14
CL - Cile 13
MA - Marocco 13
PH - Filippine 13
MY - Malesia 12
JM - Giamaica 11
PY - Paraguay 11
KR - Corea 9
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
CZ - Repubblica Ceca 8
AU - Australia 7
EG - Egitto 7
IL - Israele 7
KE - Kenya 7
TN - Tunisia 7
HN - Honduras 6
NZ - Nuova Zelanda 6
PE - Perù 6
UY - Uruguay 6
BY - Bielorussia 5
LB - Libano 5
NP - Nepal 5
OM - Oman 5
CH - Svizzera 4
JO - Giordania 4
RO - Romania 4
RS - Serbia 4
SN - Senegal 4
AL - Albania 3
AO - Angola 3
AZ - Azerbaigian 3
BH - Bahrain 3
BO - Bolivia 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
EU - Europa 3
MZ - Mozambico 3
PA - Panama 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
BZ - Belize 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GE - Georgia 2
GR - Grecia 2
HR - Croazia 2
KW - Kuwait 2
KZ - Kazakistan 2
LI - Liechtenstein 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
TH - Thailandia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CG - Congo 1
CI - Costa d'Avorio 1
EE - Estonia 1
GD - Grenada 1
GT - Guatemala 1
Totale 19.527
Città #
Singapore 1.235
Ashburn 1.112
Woodbridge 891
Fairfield 841
San Jose 653
Jacksonville 619
Houston 609
Chandler 504
Beijing 463
Ann Arbor 458
Santa Clara 429
Hong Kong 400
Seattle 337
Wilmington 331
Cambridge 283
New York 252
Nanjing 194
Izmir 188
Warsaw 172
Los Angeles 165
Ho Chi Minh City 152
Hanoi 144
Dallas 135
Princeton 134
Council Bluffs 114
Tokyo 100
Lauterbourg 97
San Diego 87
Buffalo 83
Munich 78
São Paulo 65
Boardman 63
Milan 63
Shanghai 58
Shenyang 58
Orem 54
Tianjin 52
Mexico City 51
Helsinki 48
Nanchang 47
The Dalles 40
Brussels 39
Chicago 39
Hefei 39
Hebei 38
Frankfurt am Main 37
Jiaxing 37
Toronto 37
San Mateo 34
Ferrara 32
Brooklyn 30
Vienna 30
London 29
Da Nang 28
Montreal 28
Changsha 27
Chennai 26
Jinan 24
San Francisco 24
Johannesburg 23
Ningbo 23
Washington 22
Baghdad 21
Guangzhou 21
Philadelphia 21
Denver 20
Norwalk 20
Poplar 20
Rome 20
Stockholm 20
Falls Church 19
Moscow 19
Rio de Janeiro 19
Boston 18
Mountain View 17
Turku 17
Ankara 16
Hải Dương 16
Manchester 16
Amsterdam 15
Augusta 15
Dearborn 15
Kunming 15
Leawood 15
Phoenix 15
Atlanta 14
Auburn Hills 14
Haiphong 14
Bologna 13
Medellín 13
Tashkent 13
Belo Horizonte 12
Biên Hòa 12
Falkenstein 12
Mumbai 12
Orange 12
Verona 12
Zhengzhou 12
Caracas 11
Columbus 11
Totale 13.102
Nome #
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors 333
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 279
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth. 270
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 266
Analysis of HSV isolated from patients with unilateral and bilateral herpetic keratitis 263
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 255
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 248
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 244
Characterization of a herpes simplex virus type 1 mutant resistant to benzhydrazone, a selective inhibitor of herpesvirus glycosylation 242
Herpetic vectors inhibiting angiogenesis and inducing cell suicide in gliomas 238
Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins 237
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 229
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 227
A herpes simplex virus type 1 mutant resistant to benzhydrazone, an inhibitor of glycoprotein synthesis in herpesvirus-infected cells. Preliminary mapping of benzhydrazone-resistance and of a novel syncitial mutation 225
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections 223
HSV as a vector in vaccine development and gene therapy 219
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 210
Characterization of virus obtained from MDBK cells persistently infected with a variant of herpes simplex virus type 1 strain MP [HSV-1(MP)] 205
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 205
Herpesvirus-based vaccines 205
Membrane protein pattern in hereditary spherocytosis in five subjects from north-east Italy obtained by SDS-PAGE using N,N'-diallyltartardiamide 203
Capitolo 55 Retrovirus 202
An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency. 200
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 200
Replication-competent herpes simplex vectors: design and applications 200
Expression of herpes simplex virus 1 glycoprotein B in human cells and protection of mice against lethal herpes simplex virus 1 infection 199
Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection 195
HSV as a vector in vaccine development and gene therapy 192
Herpes Simplex Virus Growth, Preparation, and Assay 191
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 187
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1 185
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 185
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide 184
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 183
Purinergic Signaling: A New Pharmacological Target Against Viruses? 180
Herpes Simplex Virus Type 1 (HSV-1) Uracil-DNA Glycosylase: Functional Expression in Escherichia coli, Biochemical Characterization, and Selective Inhibition by 6-(p-n-Octylanilino)Uracil 179
null 179
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 177
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 177
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 175
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 174
Comunicazione orale, KN: A New Vaccine Approach To Fight Mycobacterium Tuberculosis 171
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 170
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 169
Intra-tissue characteristics of chloroplasts in the lamina and petiole of mature winter leaf of Arum italicum Miller 167
Cell-type dependent sensitivity of herpes simplex virus 1 mutants to plaque development inhibition by an anti-gD monoclonal antibody. 167
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 167
Viral Vector Expressing Tat As Immunomodulatory Molecule Represent A New Vaccine Strategy Against HSV Infection 167
Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis 165
Phenotypic and genotypic characterization of locus Syn 5 in Herpes simplex virus 1. 163
IMMUNIZZAZIONE PASSIVA CON SIERO POLICLONALE NELLA CHERATITE ERPETICA SPERIMENTALE 163
Osservazioni cliniche e microbiologiche su un campione di donne controllate ambulatoriamente 163
Herpesvirus/retrovirus chimeric vectors 162
Comparative analysis of the virion polypeptides specified by Herpes simplex virus type 2 strains 161
Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection 160
EVIDENCE FOR GLYCOPROTEIN ABNORMALITY IN PLATELETS FROM PATIENTS WITH MAY-HEGGLIN ANOMALY 160
Identification of replication-competent HSV-1 Cgal(+) strain targets in a mouse model of human hepatocarcinoma xenograft 159
Synthesis and anti-HSV-1 activity of 6 substituted pyrazolo[3,4-d]pyridazin-7-one nucleosides 158
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 158
Capitolo 44 Herpesviridae 158
State of viral DNA in BK virus-transformed rabbit cells 158
Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: Protection studies against lethal viral infection in mice 154
Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model 154
Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors 151
The C-terminal cytoplasmic tail of herpes simplex virus type 1 gE protein is phosphorylated in vivo and in vitro by cellular enzymes in the absence of other viral proteins 151
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 151
HSV Recombinant Vectors for Gene Therapy 148
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 147
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 147
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses 145
Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir 144
Replication-competent herpes simplex virus type 1 mutant expressing an autofluorescent glycoprotein H fusion protein 143
Effetto sterilizzante dell'acido peracetico su siero da impiegarsi per la coltivazione in vitro delle cellule animali. 141
HSV-1 virions engineered for specific binding to cell surface receptors 139
Experimental keratitis in rabbits by human HSV-1 variants: prevention andtreatment 135
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 132
Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors 130
Transformation by defined regions of herpes simplex virus DNA. 126
Temperature-sensitive mutants of HSV-1: Complementation and partial characterization 125
Molecular diagnosis of herpes simplex encephalitis 125
Inhibition of human immunodeficiency virus reactivation from latency by tat antisense RNA and a tat transdominant negative mutant 125
Plaque dissociation of herpes sinplex viruses: biochemical and biological characters of the viral variants 123
Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses 122
APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells 122
Use of replication deficient hsv-1 as a vaccine vector for the deli vary of hiv-1 tat antigen 122
Niosomes for vaginal administration of an antiherpetic peptide 120
Vettori erpetici per la terapia genica di patologie del sistema nervoso centrale. 119
Gene therapy of the nervous system by herpes virus vectors 119
Ocular disease patterns caused by genetically related mutants of herpes simplex virus type I 117
Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA 115
Espressione in cellule umane del gene della glicoproteina B del virus dell'herpes simplex inserito in un vettore eucariotico 114
Protective immunity against genital herpes in mice obtained by non-ionic surfactant vesiclescontaining a secreted recombinant form of gB protein 113
Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays 112
Liposomes carrying anti herpetic peptides as a tool for a potential ocular vaccine 111
HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens 110
Niosomes containing HSV immunogens as possible vaccine against genital herpes 109
Virus vectors for immunoprophylaxis 108
null 107
Constitutive expression in human cells of herpes simplex type 1 glycoprotein B gene cloned in an episomal eukaryotic vector 106
Sequences homologous to two separate transforming regions of herpes simplex virus DNA are linked in two genital tumors 106
Totale 17.024
Categoria #
all - tutte 84.613
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.748
Totale 90.361


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.407 58 137 86 83 76 48 70 65 56 91 124 513
2022/20231.152 131 48 64 149 176 186 42 106 143 10 68 29
2023/2024672 68 78 29 24 60 180 38 39 15 7 7 127
2024/20252.197 59 48 186 88 280 249 51 97 270 257 332 280
2025/20267.128 755 273 643 959 1.054 496 761 357 666 751 312 101
2026/2027230 230 0 0 0 0 0 0 0 0 0 0 0
Totale 19.634